• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-CGRP therapies for migraine in multiple sclerosis patients.

作者信息

Gonzalez-Martinez Alicia, Bose Gauruv, Chitnis Tanuja

机构信息

Translational Neuroimmunology Research Center (TNRC), Ann Romney Center for Neurologic Diseases (ARCND), Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.

Brigham Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Mult Scler. 2022 Nov;28(13):2149-2150. doi: 10.1177/13524585221096353. Epub 2022 May 14.

DOI:10.1177/13524585221096353
PMID:35575242
Abstract
摘要

相似文献

1
Anti-CGRP therapies for migraine in multiple sclerosis patients.用于多发性硬化症患者偏头痛的降钙素基因相关肽（CGRP）拮抗剂疗法
Mult Scler. 2022 Nov;28(13):2149-2150. doi: 10.1177/13524585221096353. Epub 2022 May 14.
2
Two cases of lesions in brainstem in multiple sclerosis and refractory migraine.多发性硬化症和难治性偏头痛中脑干病变的两例病例
Headache. 2007 Jun;47(6):852-4. doi: 10.1111/j.1526-4610.2007.00823.x.
3
Anti-calcitonin gene-related peptide monoclonal antibodies for neuropathic pain in patients with migraine headache.抗降钙素基因相关肽单克隆抗体治疗偏头痛患者的神经病理性疼痛。
Muscle Nerve. 2021 Apr;63(4):563-567. doi: 10.1002/mus.27153. Epub 2021 Jan 8.
4
Galcanezumab for the prevention of migraine.加巴喷丁预防偏头痛。
Pain Manag. 2021 Mar;11(2):101-112. doi: 10.2217/pmt-2020-0030. Epub 2020 Dec 9.
5
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.降钙素基因相关肽（CGRP）拮抗剂治疗的历史和综述：从转化研究到治疗。
Headache. 2018 Nov;58 Suppl 3:238-275. doi: 10.1111/head.13379. Epub 2018 Sep 22.
6
Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.降钙素基因相关肽（CGRP）靶向治疗作为偏头痛的预防和急性治疗——单克隆抗体和 gepants。
Prog Brain Res. 2020;255:143-170. doi: 10.1016/bs.pbr.2020.06.019. Epub 2020 Jul 22.
7
Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.降钙素基因相关肽 (CGRP) 与偏头痛：当前认识和研发状况。
Headache. 2013 Sep;53(8):1230-44. doi: 10.1111/head.12179. Epub 2013 Jul 12.
8
Erenumab in the treatment of migraine.erenumab用于偏头痛的治疗。
Pain Manag. 2018 Nov 1;8(6):415-426. doi: 10.2217/pmt-2018-0037. Epub 2018 Sep 21.
9
[Novel migraine treatment with CGRP-related monoclonal antibodies].[使用与降钙素基因相关肽（CGRP）有关的单克隆抗体进行偏头痛的新型治疗]
Rinsho Shinkeigaku. 2020 Oct 24;60(10):668-676. doi: 10.5692/clinicalneurol.cn-001469. Epub 2020 Sep 5.
10
Treatment of migraine with monoclonal antibodies.偏头痛的单克隆抗体治疗。
Expert Opin Biol Ther. 2022 Jun;22(6):707-716. doi: 10.1080/14712598.2022.2072207. Epub 2022 May 13.

引用本文的文献

1
Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.偏头痛患者的降钙素基因相关肽（CGRP）拮抗剂与免疫调节联合治疗：走向综合管理策略
J Neurol. 2025 Jun 3;272(6):443. doi: 10.1007/s00415-025-13177-y.
2
Clinical Insights and Radiological Features on Multiple Sclerosis Comorbid with Migraine.多发性硬化合并偏头痛的临床见解与放射学特征
J Clin Med. 2025 Jan 16;14(2):561. doi: 10.3390/jcm14020561.
3
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study.
抗降钙素基因相关肽抗体与其他用于不同疾病的单克隆抗体的关联：一项多中心、前瞻性、队列研究。
Eur J Neurol. 2024 Dec;31(12):e16450. doi: 10.1111/ene.16450. Epub 2024 Sep 16.
4
Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis.降钙素基因相关肽单克隆抗体在多发性硬化症患者偏头痛治疗中的应用
Int J MS Care. 2024 May-Jun;26(3):104-107. doi: 10.7224/1537-2073.2023-013. Epub 2024 May 16.
5
Headache in Multiple Sclerosis: A Narrative Review.多发性硬化症中的头痛：一篇叙述性综述。
Medicina (Kaunas). 2024 Mar 30;60(4):572. doi: 10.3390/medicina60040572.